Impact of symptoms of anxiety and depression on COPD Assessment Test scoress

European Respiratory Journal

Volumn 43, Issue 3, 2014, Pages 898-900

  Hilmarsen, Christina W ^a   Wilke, Sarah ^b   Engan, Harald ^a,c   Spruit, Martijn A ^b   Rodenburg, Johan ^a   Janssen, Daisy J A ^b   Steinshamn, Sigurd ^a,d,e   Jones, Paul W ^f   Wouters, Emiel F M ^b,g   Oldervoll, Line ^a,e   Franssen, Frits M E ^b  

^a Norwegian Heart and Lung Patient Organization   (Norway)

^b CIRO+   (Netherlands)

^c MID SWEDEN UNIVERSITY   (Sweden)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ANXIETY; ANXIETY DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COPD ASSESSMENT TEST; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MIDDLE AGED; OBESITY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM;

AGED; ANXIETY; COMORBIDITY; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SYMPTOM ASSESSMENT;

EID: 84895539467     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00163913     Document Type: Letter

References (10)

1. Janssen DJ, Spruit MA, Leue C, et al. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis 2010; 7: 147-157.
2. Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 2012; 12: 53.
3. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
4. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
5. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
6. Sillen MJ, Franssen FM, Delbressine JM, et al. Heterogeneity in clinical characteristics and co-morbidities in dyspneic individuals with COPD GOLD D: findings of the DICES trial. Respir Med 2013; 107: 1186-1194.
7. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
8. Papaioannou AI, Bartziokas K, Tsikrika S, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J 2013; 41: 815-823.
9. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127: 1205-1211.
10. Lee YS, Park S, Oh YM, et al. Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study. J Korean Med Sci 2013; 28: 1048-1054.